Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
OncoTargets and Therapy
Volume 15, 2022 - Issue
Review
Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations
Anna Vaynrub1 Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
https://orcid.org/0000-0002-8544-1758View further author information
https://orcid.org/0000-0002-8544-1758View further author information, John H Healey2 Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USAhttps://orcid.org/0000-0002-0802-1186View further author information
https://orcid.org/0000-0002-0802-1186View further author information, William Tap3 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAhttps://orcid.org/0000-0001-7779-2796View further author information
https://orcid.org/0000-0001-7779-2796View further author information & Max Vaynrub2 Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0001-7364-3259View further author information
https://orcid.org/0000-0001-7364-3259View further author information